Pharmaceutical Preparations · DE · CIK 1501989
Developing conditionally activated biologics for oncology using PROBODY technology
Comparable business profile · signals at a glance
In the 90 days to Mar 17, 2026: 4 sold $1.2M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 17, 2026 | Mccarthy Sean A.CEO | Sell | 118,969 | $6.42 | $764K |
| Mar 17, 2026 | Belvin MarciaSVP, Chief Scientific Officer | Sell | 31,492 | $6.42 | $202K |
| Mar 17, 2026 | Chu Yu-WayeChief Medical Officer | Sell | 21,279 | $6.42 | $137K |
| Mar 17, 2026 | Ogden ChristopherChief Financial Officer | Sell | 19,323 | $6.42 | $124K |
| Nov 6, 2025 | Mccarthy Sean A.CEO | Sell | 101,793 | $4.54 | $462K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.